Table 3.
In vitro antioxidant capacity of the extracts.
| Sample | DPPH (TE mg/mL) * | FRAP (TE mM) * | ABTS+ (TE mM) * |
|---|---|---|---|
| M | 2.610 ± 0.154 | 17.030 ± 0.959 | 9.381 ± 1.261 |
| S20 | 6.109 ± 0.345 | 22.648 ± 0.354 | 11.907 ± 0.394 |
| S40 | 6.154 ± 0.198 | 20.675 ± 0.357 | 11.843 ± 0.477 |
| S60 | 5.876 ± 0.057 | 23.620 ± 0.510 | 16.136 ± 0.868 |
| T24 | 6.192 ± 0.170 | 18.414 ± 0.479 | 10.328 ± 0.665 |
| T26 | 6.140 ± 0.075 | 20.114 ± 1.347 | 10.960 ± 1.218 |
| T28 | 6.123 ± 0.092 | 21.181 ± 0.543 | 10.960 ± 0.895 |
| T44 | 6.074 ± 0.087 | 20.944 ± 0.830 | 13.359 ± 0.717 |
| T46 | 6.128 ± 0.019 | 22.090 ± 0.674 | 12.159 ± 0.568 |
| T48 | 6.116 ± 0.029 | 19.126 ± 0.725 | 12.854 ± 0.934 |
| U13 | 3.796 ± 0.085 | 17.505 ± 0.428 | 4.331 ± 0.219 |
| U14 | 3.757 ± 0.045 | 17.940 ± 0.181 | 3.826 ± 0.189 |
| U15 | 6.425 ± 0.017 | 23.395 ± 0.585 | 9.318 ± 0.189 |
| U23 | 4.737 ± 0.017 | 22.446 ± 0.068 | 7.361 ± 1.588 |
| U24 | 5.639 ± 0.061 | 18.197 ± 0.332 | 8.308 ± 0.394 |
| U25 | 6.336 ± 0.061 | 13.907 ± 0.181 | 10.202 ± 0.289 |
| U33 | 2.653 ± 0.088 | 16.951 ± 0.49f4 | 8.056 ± 0.219 |
| U34 | 4.476 ± 0.029 | 15.330 ± 0.137 | 9.760 ± 0.477 |
| U35 | 9.160 ± 0.041 | 26.676 ± 0.342 | 12.475 ± 0.477 |
| UT | 8.256 ± 0.174 | 20.074 ± 0.298 | 6.604 ± 0.219 |
* Concentrations were expressed as mean ± SD. DPPH—(2,2-Diphenyl-1-(2,4,6-trinitrophenyl)hydrazyl); TE mg/mL—mg Trolox equivalents per mL extract; FRAP—Ferric-Reducing Antioxidant Power; TE mM—mM Trolox equivalents; ABTS+—diammonium 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonate; mM TE—mM Trolox equivalents.